2022. A Randomised Single Blind Controlled Trial to Assess Effect of Amalaki (Emblica Officinalis) 30 CH of Type 2 Diabetes Mellitus Taking Conventional Treatment as Add on Therapy : A Pilot Study . Advancements in Homeopathic Research. 4, 4 (Aug. 2022), 43–53.